Clinical Trial Update: Screening Protocol

View source ↗

Summary

Clinical trial NCT06135727, sponsored by Topcon Corporation for glaucoma, has been terminated, with an update focusing on the screening protocol.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Snippet

Sponsor: Topcon Corporation | Conditions: Glaucoma | Status: TERMINATED